OxySure Launches New Product – Double Wall Cabinet for AED/OxySure Combination Set
Frisco, Texas, USA, July 17, 2013 – OxySure Systems, Inc. (OXYS: OTCQB) (“OxySure,” or the “Company”), a medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its “oxygen from powder” technology today announced that the Company launched a new double wall mounted cabinet to house a combination AED/OxySure system.
This new product allows customers to house and display an AED of their choosing, along with an OxySure Model 615 unit in the same wall cabinet, allowing easy, one-step access, reducing response time when seconds count, in a cardiac arrest or other medical emergency. In addition, by housing both their AED and OxySure units in the same cabinet, the Company believes that customers will save wall space and expense, and will reduce installation and maintenance requirements. The cabinet comprises a powder coated finish and clear impact resistant acrylic window that provides durability and protection. The unit also comes fully alarmed with a key switch conveniently located in the front. A magnetic door latch provides solid closure and trouble free opening.
The Company has previously announced the addition of six AED brands to its product portfolio, including Zoll, Philips, Cardiac Science, Physio Control, Defibtech and Heartsine. In a cardiac arrest emergency the OxySure Model 615 is intended to be used post-resuscitation. In most other medical emergencies the OxySure Model 615 is intended for general emergency use, prior to the arrival of the first responders.
One of the first customers to take delivery of ten of the new OxySure double cabinet systems is the First Baptist Church of Dallas. Ron Cresswell of First Baptist Church stated: “We are very excited to be deploying the new AED/OxySure combination wall cabinets. This unit creates a compact way to pre-position both an AED and an OxySure unit, and it eliminates the need for multiple keys and multiple access points in an emergency, reducing response time and risk.”
Julian T. Ross, CEO of OxySure Systems, Inc. stated: “We are pleased to be offering our customers and distributors this new combination wall cabinet. We have developed this product based on customer feedback, and we believe it enhances the appeal of the AED and OxySure Model 615 as a combination set, and our product portfolio in general.”
For a video demonstration of the new AED/OxySure wall box, please click here: http://www.youtube.com/watch?v=VgQ4VDNqKKo
The AED/OxySure combination wall cabinet has a manufacturer suggested retail price of $369. For order information, please email ehuntsberry@oxysure.com or call Ed Huntsberry at (+1) 972-294-6559.
About OxySure Systems, Inc.
OxySure Systems, Inc. (OTCQB: OXYS) is a medical technology company that focuses on the design, manufacture and distribution of specialty respiratory and medical solutions. The company pioneered a safe and easy to use solution to produce medically pure (USP) oxygen from inert powders. The company owns numerous issued patents and patents pending on this technology which makes the provision of emergency oxygen safer, more accessible and easier to use than traditional oxygen provision systems. OxySure’s products improve access to emergency oxygen that affects the survival, recovery and safety of individuals in several areas of need: (1) Public and private places and settings where medical emergencies can occur; (2) Individuals at risk for cardiac, respiratory or general medical distress needing immediate help prior to emergency medical care arrival; and (3) Those requiring immediate protection and escape from exposure situations or oxygen-deficient situations in industrial, mining, military, or other “Immediately Dangerous to Life or Health” (IDLH) environments. www.OxySure.com
Forward-Looking Statements
This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements contained in this release that are not historical facts, including, without limitation, statements that relate to the Company's expectations with regard to the future impact on the Company's results from new products in development, may be deemed to be forward-looking statements. Words such as "expects", "intends", "plans", "may", "could", "should", "anticipates", "likely", "believes" and words of similar import also identify forward-looking statements. These statements are subject to risks and uncertainties. Forward-looking statements are based on current facts and analyses and other information that are based on forecasts of future results, estimates of amounts not yet determined and assumptions of management. Readers are urged not to place undue reliance on the forward-looking statements, which speak only as of the date of this release. Except as may be required under applicable law, we assume no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this release. Additional information on risks and other factors that may affect the business and financial results of OxySure Systems, Inc. can be found in the filings of OxySure Systems, Inc. with the U.S. Securities and Exchange Commission.
Investor Relations Contacts:
Barwicki Investor Relations
Andrew Barwicki, President
Tel: +1-516-662-9461
Email: andrew@barwicki.com
Investor Relations WS
Chris Hagerman
Tel: +1-208-361-6624
Email: jamespr@oxysure.com
Tags:
